OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) Double-Blind Crossover Trial in Patients With Low-Renin Hypertension and Elevated Aldosterone-Renin Ratio
Susan J. Hood, Kevin Taylor, Michael J. Ashby, et al.
Circulation (2007) Vol. 116, Iss. 3, pp. 268-275
Open Access | Times Cited: 102
Susan J. Hood, Kevin Taylor, Michael J. Ashby, et al.
Circulation (2007) Vol. 116, Iss. 3, pp. 268-275
Open Access | Times Cited: 102
Showing 1-25 of 102 citing articles:
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial
Bryan Williams, Thomas M. MacDonald, S. V. Morant, et al.
The Lancet (2015) Vol. 386, Iss. 10008, pp. 2059-2068
Open Access | Times Cited: 1066
Bryan Williams, Thomas M. MacDonald, S. V. Morant, et al.
The Lancet (2015) Vol. 386, Iss. 10008, pp. 2059-2068
Open Access | Times Cited: 1066
First-line drugs for hypertension
James M Wright, Vijaya M Musini, Rupam Gill
Cochrane library (2018) Vol. 2018, Iss. 4
Open Access | Times Cited: 440
James M Wright, Vijaya M Musini, Rupam Gill
Cochrane library (2018) Vol. 2018, Iss. 4
Open Access | Times Cited: 440
Relationship Between Overnight Rostral Fluid Shift and Obstructive Sleep Apnea in Drug-Resistant Hypertension
Oded Friedman, T. Douglas Bradley, Christopher T. Chan, et al.
Hypertension (2010) Vol. 56, Iss. 6, pp. 1077-1082
Open Access | Times Cited: 209
Oded Friedman, T. Douglas Bradley, Christopher T. Chan, et al.
Hypertension (2010) Vol. 56, Iss. 6, pp. 1077-1082
Open Access | Times Cited: 209
A Lifetime of Aldosterone Excess: Long-Term Consequences of Altered Regulation of Aldosterone Production for Cardiovascular Function
John Connell, Scott M. MacKenzie, E. Marie Freel, et al.
Endocrine Reviews (2008) Vol. 29, Iss. 2, pp. 133-154
Open Access | Times Cited: 178
John Connell, Scott M. MacKenzie, E. Marie Freel, et al.
Endocrine Reviews (2008) Vol. 29, Iss. 2, pp. 133-154
Open Access | Times Cited: 178
Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial
Morris J. Brown, Gordon T. McInnes, Cheraz Cherif Papst, et al.
The Lancet (2011) Vol. 377, Iss. 9762, pp. 312-320
Closed Access | Times Cited: 167
Morris J. Brown, Gordon T. McInnes, Cheraz Cherif Papst, et al.
The Lancet (2011) Vol. 377, Iss. 9762, pp. 312-320
Closed Access | Times Cited: 167
The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension
Jenifer M. Brown, Cassianne Robinson‐Cohen, Miguel Ángel Luque-Fernández, et al.
Annals of Internal Medicine (2017) Vol. 167, Iss. 9, pp. 630-630
Open Access | Times Cited: 159
Jenifer M. Brown, Cassianne Robinson‐Cohen, Miguel Ángel Luque-Fernández, et al.
Annals of Internal Medicine (2017) Vol. 167, Iss. 9, pp. 630-630
Open Access | Times Cited: 159
Aldosterone and arterial hypertension
Andreas Tomaschitz, Stefan Pilz, Eberhard Ritz, et al.
Nature Reviews Endocrinology (2009) Vol. 6, Iss. 2, pp. 83-93
Closed Access | Times Cited: 143
Andreas Tomaschitz, Stefan Pilz, Eberhard Ritz, et al.
Nature Reviews Endocrinology (2009) Vol. 6, Iss. 2, pp. 83-93
Closed Access | Times Cited: 143
Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial
Morris J. Brown, Bryan Williams, S. V. Morant, et al.
The Lancet Diabetes & Endocrinology (2015) Vol. 4, Iss. 2, pp. 136-147
Open Access | Times Cited: 123
Morris J. Brown, Bryan Williams, S. V. Morant, et al.
The Lancet Diabetes & Endocrinology (2015) Vol. 4, Iss. 2, pp. 136-147
Open Access | Times Cited: 123
New Drugs and Technologies
Nathalie Bergeron, Binh An P. Phan, Yunchen Ding, et al.
Circulation (2015)
Open Access | Times Cited: 92
Nathalie Bergeron, Binh An P. Phan, Yunchen Ding, et al.
Circulation (2015)
Open Access | Times Cited: 92
Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: a systematic review and meta-analysis
Sonali Shah, Jinghong Zhang, Stella May Gwini, et al.
Journal of Human Hypertension (2024) Vol. 38, Iss. 5, pp. 383-392
Open Access | Times Cited: 13
Sonali Shah, Jinghong Zhang, Stella May Gwini, et al.
Journal of Human Hypertension (2024) Vol. 38, Iss. 5, pp. 383-392
Open Access | Times Cited: 13
Exploratory study on the relationship between urinary sodium/potassium ratio, salt intake, and the antihypertensive effect of esaxerenone: the ENaK Study
Tomohiro Katsuya, Yoshito Inobe, Kazuaki Uchiyama, et al.
Hypertension Research (2024) Vol. 47, Iss. 4, pp. 835-848
Open Access | Times Cited: 12
Tomohiro Katsuya, Yoshito Inobe, Kazuaki Uchiyama, et al.
Hypertension Research (2024) Vol. 47, Iss. 4, pp. 835-848
Open Access | Times Cited: 12
Primary aldosteronism: an update on screening, diagnosis and treatment
Gian Paolo Rossi, Achille C. Pessina, Anthony M. Heagerty
Journal of Hypertension (2008) Vol. 26, Iss. 4, pp. 613-621
Closed Access | Times Cited: 123
Gian Paolo Rossi, Achille C. Pessina, Anthony M. Heagerty
Journal of Hypertension (2008) Vol. 26, Iss. 4, pp. 613-621
Closed Access | Times Cited: 123
Aliskiren
Morris J. Brown
Circulation (2008) Vol. 118, Iss. 7, pp. 773-784
Open Access | Times Cited: 110
Morris J. Brown
Circulation (2008) Vol. 118, Iss. 7, pp. 773-784
Open Access | Times Cited: 110
Common Secondary Causes of Resistant Hypertension and Rational for Treatment
Charles Faselis, Michael Doumas, Vasilios Papademetriou
International Journal of Hypertension (2011) Vol. 2011, pp. 1-17
Open Access | Times Cited: 85
Charles Faselis, Michael Doumas, Vasilios Papademetriou
International Journal of Hypertension (2011) Vol. 2011, pp. 1-17
Open Access | Times Cited: 85
Aldosterone synthase inhibition in humans
Michel Azizi, Laurence Amar, Joël Ménard
Nephrology Dialysis Transplantation (2012) Vol. 28, Iss. 1, pp. 36-43
Open Access | Times Cited: 83
Michel Azizi, Laurence Amar, Joël Ménard
Nephrology Dialysis Transplantation (2012) Vol. 28, Iss. 1, pp. 36-43
Open Access | Times Cited: 83
A Double-Blind, Placebo-Controlled, Crossover Trial Comparing the Effects of Amiloride and Hydrochlorothiazide on Glucose Tolerance in Patients With Essential Hypertension
Anna Stears, Sarah H. Woods, Michaela Watts, et al.
Hypertension (2012) Vol. 59, Iss. 5, pp. 934-942
Open Access | Times Cited: 77
Anna Stears, Sarah H. Woods, Michaela Watts, et al.
Hypertension (2012) Vol. 59, Iss. 5, pp. 934-942
Open Access | Times Cited: 77
Salt sensitivity: a review with a focus on non-Hispanic blacks and Hispanics
Safiya Richardson, Barry I. Freedman, David H. Ellison, et al.
Journal of the American Society of Hypertension (2013) Vol. 7, Iss. 2, pp. 170-179
Open Access | Times Cited: 74
Safiya Richardson, Barry I. Freedman, David H. Ellison, et al.
Journal of the American Society of Hypertension (2013) Vol. 7, Iss. 2, pp. 170-179
Open Access | Times Cited: 74
Role of the renin–angiotensin system in kidney development and programming of adult blood pressure
Lucas Ferreira de Almeida, Signe Skou Tofteng, Kirsten Madsen, et al.
Clinical Science (2020) Vol. 134, Iss. 6, pp. 641-656
Closed Access | Times Cited: 65
Lucas Ferreira de Almeida, Signe Skou Tofteng, Kirsten Madsen, et al.
Clinical Science (2020) Vol. 134, Iss. 6, pp. 641-656
Closed Access | Times Cited: 65
First-line diuretics versus other classes of antihypertensive drugs for hypertension
Marcia Reinhart, Lorri Puil, Douglas M Salzwedel, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Closed Access | Times Cited: 20
Marcia Reinhart, Lorri Puil, Douglas M Salzwedel, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Closed Access | Times Cited: 20
Aldosterone-receptor antagonism in hypertension
Pieter M. Jansen, AH Jan Danser, Ben P.M. Imholz, et al.
Journal of Hypertension (2009) Vol. 27, Iss. 4, pp. 680-691
Closed Access | Times Cited: 91
Pieter M. Jansen, AH Jan Danser, Ben P.M. Imholz, et al.
Journal of Hypertension (2009) Vol. 27, Iss. 4, pp. 680-691
Closed Access | Times Cited: 91
Renin: friend or foe?
M. J Brown
Heart (2007) Vol. 93, Iss. 9, pp. 1026-1033
Open Access | Times Cited: 83
M. J Brown
Heart (2007) Vol. 93, Iss. 9, pp. 1026-1033
Open Access | Times Cited: 83
Regulation--the real threat to clinical research
Paul M. Stewart, Anna Stears, Jeremy Tomlinson, et al.
BMJ (2008) Vol. 337, Iss. oct16 2, pp. a1732-a1732
Closed Access | Times Cited: 75
Paul M. Stewart, Anna Stears, Jeremy Tomlinson, et al.
BMJ (2008) Vol. 337, Iss. oct16 2, pp. a1732-a1732
Closed Access | Times Cited: 75
Spironolactone for hypertension
Josh Batterink, Sarah Stabler, Aaron M Tejani, et al.
Cochrane library (2010)
Closed Access | Times Cited: 73
Josh Batterink, Sarah Stabler, Aaron M Tejani, et al.
Cochrane library (2010)
Closed Access | Times Cited: 73
Pharmacotherapy for hypertension in adults 60 years or older
Vijaya M Musini, Aaron M Tejani, Ken Bassett, et al.
Cochrane library (2019) Vol. 2020, Iss. 1
Open Access | Times Cited: 54
Vijaya M Musini, Aaron M Tejani, Ken Bassett, et al.
Cochrane library (2019) Vol. 2020, Iss. 1
Open Access | Times Cited: 54
Renin Phenotypes Characterize Vascular Disease, Autonomous Aldosteronism, and Mineralocorticoid Receptor Activity
Gregory L. Hundemer, René Baudrand, Jenifer M. Brown, et al.
The Journal of Clinical Endocrinology & Metabolism (2017) Vol. 102, Iss. 6, pp. 1835-1843
Open Access | Times Cited: 49
Gregory L. Hundemer, René Baudrand, Jenifer M. Brown, et al.
The Journal of Clinical Endocrinology & Metabolism (2017) Vol. 102, Iss. 6, pp. 1835-1843
Open Access | Times Cited: 49
